Firms
Theme

OMC

Omnicom Group Inc. · NYSE

News

3 latest

Zacks Investment Research

Omnicom (OMC) Earnings Expected to Grow: Should You Buy?

Omnicom is expected to report Q3 2026 earnings of $2.68 per share (up 19.6% YoY) with revenues of $6.15 billion (up 52.3% YoY). However, the company's Earnings ESP is -1.75%, indicating recent analyst pessimism, combined with a Zacks Rank #3, making it difficult to predict an earnings beat. The stock is not considered a compelling earnings-beat candidate.

Zacks Investment Research

Here's Why Investors Should Hold OMC Stock in Their Portfolios for Now

Omnicom (OMC) is expected to see 2026 earnings rise 21.4% and revenues grow 49.6%, driven by post-Interpublic acquisition synergies, AI-enabled marketing capabilities, and strong shareholder returns. However, the company faces headwinds from weak advertising trends, $10.2B in long-term debt, and elevated integration costs. OMC currently holds a Zacks Rank #3 (Hold) rating.

Mentions OMC

The Motley Fool

Omnicom: 3 Key Takeaways for Long-Term Investors

Omnicom reported strong Q3 2026 results with ~5% organic revenue growth and 7.2% Q3 organic growth. The company is realizing $900 million in cost synergies from its Interpublic acquisition, expanding adjusted EBITA margins by 2 percentage points to 18.2%. Management is completing portfolio pruning of non-core assets and executing a $5 billion share buyback program that has already reduced shares by 12% since year-end 2025, positioning the company for reinvestment in digital services and AI technology.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $OMC · 0 threads

Sign in to post on $OMC

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev